PMA device
Omnicarbon Cardiac Valve Prosthesis
Medical Cv, Inc. · Heart-Valve, Mechanical (LWQ, Class III) · First FDA decision Jul 26, 2001, newest Oct 29, 2002Aortic stenosisMitral regurgitation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
0
Naming "Omnicarbon"
MAUDE reports
0
Brand "Omnicarbon", since 2015
PubMed studies
61
Mentioning "Omnicarbon"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Omnicarbon Cardiac Valve Prosthesis
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- OMNICARBON CARDIAC VALVE PROSTHESISPMA supplement
P830039-S011 · Decided Oct 29, 2002 · 175 days after receipt · Normal 180 Day Track
Device type: HEART-VALVE, MECHANICAL (LWQ) · Cardiology
- OMNICARBON CARDIAC VALVE PROSTHESISPMA supplement
P830039-S007 · Decided Jul 26, 2001 · 1,736 days after receipt · Panel Track
Device type: HEART-VALVE, MECHANICAL (LWQ) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Omnicarbon", any status and sponsor, newest update first.
No registered device study names "Omnicarbon".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Omnicarbon", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LWQ
3,896 reports: 550 malfunction, 2,935 injury, 400 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Omnicarbon"[tiab]. The summary above synthesizes these.
- Assessment of effective orifice area of prosthetic aortic valves with Doppler echocardiography: an in vivo and in vitro study.
Bech-Hanssen O, Caidahl K, Wallentin I, et al. · J Thorac Cardiovasc Surg · 2001Research Support, Non-U.S. Gov't
- A comparative study in patients with Omnicarbon and Björk-Shiley heart valve replacement.
Otaki M · Int Surg · 1993Comparative Study
- Aortic prosthetic valve design and size: relation to Doppler echocardiographic findings and pressure recovery- an in vitro study.
Bech-Hanssen O, Caidahl K, Wallentin I, et al. · J Am Soc Echocardiogr · 2000Comparative Study
- Ten years' experience of aortic valve replacement with the Omnicarbon valve prosthesis.
Abe T, Kamata K, Kuwaki K, et al. · Ann Thorac Surg · 1996Comparative Study
- Thrombogenic influence of biomaterials in patients with the Omni series heart valve: pyrolytic carbon versus titanium.
Phillips SJ · ASAIO J · 2001Comparative Study, Review
- [Valve replacement with the Omnicarbon valve prosthesis. A 10-year follow-up].
Florez S, Di Stefano S, Carrascal Y, et al. · Arq Bras Cardiol · 2005English Abstract
- Fourteen year experience with the omnicarbon prosthetic heart valve.
Misawa Y, Fuse K, Saito T, et al. · ASAIO J · 2001
- Mechanical heart valves: 50 years of evolution.
Gott VL, Alejo DE, Cameron DE · Ann Thorac Surg · 2003Historical Article, Research Support, Non-U.S. Gov't
- A six-year experience with the omnicarbon valve in North American patients.
Carrier J, Teijeira J, Greentree D, et al. · J Card Surg · 2004Research Support, Non-U.S. Gov't
- Nine-year follow up of the omnicarbon prosthesis in the aortic position.
Hurlé A, Gómez-Plana J, Meseguer J, et al. · J Heart Valve Dis · 2002
- Omnicarbon 21 mm aortic valve prosthesis: in vitro hydrodynamic and echo-Doppler study.
Dumont K, Segers R, Vandenberghe S, et al. · Int J Artif Organs · 2002Research Support, Non-U.S. Gov't
- Changes in turbulence with rotation of the omnicarbon prosthesis.
Travis BR, Nyboe C, Christensen TD, et al. · ASAIO J · 2007Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
Other devices of this type
Also filed under product code LWQ.
- On-X (R) Prosthetic Heart ValveOn-X Life Technologies, Inc. · PMA 2017
- CARBOMEDICS Prosthetic Heart ValveCorcym S.r.l. · PMA 2025
- Ats Open Pivot Bileaflet Heart ValvesMedtronic Ats Medical, Inc. · PMA 2007
- SJM Masters HP Valved GraftAbbott Medical · PMA 2020
- St Jude Medical Mechanical Heart ValveAbbott Medical · PMA 2008
- On-X Ascending Aortic ProsthesisOn-X Life Technologies, Inc. · PMA 2021
- Open Pivot Heart Valve & Open Pivotaortic Valved GraftMedtronic Ats Medical, Inc. · PMA 2013
- SJM Masters Series Mechanical Heart Valve, 15mm HPAbbott Medical · PMA 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.